Skip to main content

Peer Review reports

From: Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials

Original Submission
9 Jun 2022 Submitted Original manuscript
29 Jun 2022 Reviewed Reviewer Report
5 Jul 2022 Reviewed Reviewer Report
10 Jul 2022 Reviewed Reviewer Report
24 Jul 2022 Author responded Author comments - Xuelei Ma
Resubmission - Version 2
24 Jul 2022 Submitted Manuscript version 2
1 Aug 2022 Reviewed Reviewer Report
2 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
10 Aug 2022 Editorially accepted
26 Aug 2022 Article published 10.1186/s12885-022-10015-6

You can find further information about peer review here.

Back to article page